Gallagher, KevinBhatt, NikitaClement, KeiranZimmermann, EleanorKhadhouri, SinanMacLennan, StevenKulkarni, MeghanaGaba, FortisAnbarasan, ThineskrishnaAsif, AquaLight, AlexanderNg, AlexanderChan, VinsonNathan, ArjunCooper, DavidAucott, LornaMarcq, GautierTeoh, Jeremy Yuen-ChunHensley, PatrickDuncan, EilidhGoulao, BeatrizO'Brien, TimNielsen, MatthewMariappan, ParamananthanKasivisvanathan, Veeru2023-07-102023-07-102023-06-15Gallagher, K, Bhatt, N, Clement, K, Zimmermann, E, Khadhouri, S, MacLennan, S, Kulkarni, M, Gaba, F, Anbarasan, T, Asif, A, Light, A, Ng, A, Chan, V, Nathan, A, Cooper, D, Aucott, L, Marcq, G, Teoh, J Y-C, Hensley, P, Duncan, E, Goulao, B, O'Brien, T, Nielsen, M, Mariappan, P & Kasivisvanathan, V 2023, 'Audit, Feedback, and Education to Improve Quality and Outcomes in Transurethral Resection and Single-Instillation Intravesical Chemotherapy for Nonmuscle Invasive Bladder Cancer Treatment : Protocol for a Multicenter International Observational Study With an Embedded Cluster Randomized Trial', JMIR Research Protocols, vol. 12, e42254. https://doi.org/10.2196/422541929-0748unpaywall: 10.2196/42254ORCID: /0000-0002-2691-8421/work/138534345ORCID: /0000-0001-6277-7972/work/138534602ORCID: /0000-0002-1009-9732/work/189638441https://hdl.handle.net/2164/21161Acknowledgments We would like to acknowledge the input and expertise of our protocol external peer reviewers: Christopher Blick, Ashish Kamat, Jim Catto, Hugh Mostafid, Richard Sylvester, and John McGrath. This study was supported by the Rosetrees Trust grant CF1\100002, the Urology Foundation, Action Bladder Cancer UK, Karl Storz agreement, Photocure agreement, Medac Pharma agreement, and the British Journal of Urology International Charity. None of the study funders had any academic input to the study design analysis or reporting. This study was sponsored by British Urology Researchers in Surgical Training. Funding Information: We would like to acknowledge the input and expertise of our protocol external peer reviewers: Christopher Blick, Ashish Kamat, Jim Catto, Hugh Mostafid, Richard Sylvester, and John McGrath. This study was supported by the Rosetrees Trust grant CF1\100002, the Urology Foundation, Action Bladder Cancer UK, Karl Storz agreement, Photocure agreement, Medac Pharma agreement, and the British Journal of Urology International Charity. None of the study funders had any academic input to the study design analysis or reporting. This study was sponsored by British Urology Researchers in Surgical Training. Funding Information: This study has received funding from 3 industry sources—Karl Storz, Photocure, and Medac Pharma. Funds were provided as unrestricted grants with no influence on the design, analysis, or reporting of the study. PM is a designer and chief investigator for the Scot BC Quality OPS clinical project. Publisher Copyright: ©Kevin Gallagher, Nikita Bhatt, Keiran Clement, Eleanor Zimmermann, Sinan Khadhouri, Steven MacLennan, Meghana Kulkarni, Fortis Gaba, Thineskrishna Anbarasan, Aqua Asif, Alexander Light, Alexander Ng, Vinson Chan, Arjun Nathan, David Cooper, Lorna Aucott, Gautier Marcq, Jeremy Yuen-Chun Teoh, Patrick Hensley, Eilidh Duncan, Beatriz Goulao, Tim O'Brien, Matthew Nielsen, Paramananthan Mariappan, Veeru Kasivisvanathan.15736697engSDG 3 - Good Health and Well-beingTURBTBladder cancerquality improvementperformance feedbackTRANSURETHRAL RESECTIONurologyoncologyrecurrencesurgerysurgicalquality indicatorperformanceevaluationfeedbackRC0254 Neoplasms. Tumors. Oncology (including Cancer)RC0254Journal article10.2196/42254http://www.scopus.com/inward/record.url?scp=85163806863&partnerID=8YFLogxK12